Navigation Links
Tuberculosis Global Clinical Trials Review, H2, 2013
Date:11/18/2013

(PRWEB) November 18, 2013

Summary

GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H2, 2013" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Tuberculosis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Tuberculosis 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Otsuka Pharmaceutical Co., Ltd. 35
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 35
Janssen Infectious Diseases 36
Clinical Trial Overview of Janssen Infectious Diseases 36
Tibotec BVBA 37
Clinical Trial Overview of Tibotec BVBA 37
Alaeras, Inc 38
Clinical Trial Overview of Alaeras, Inc 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vakzine Projekt Management GmbH 40
Clinical Trial Overview of Vakzine Projekt Management GmbH 40
Intercell AG 41
Clinical Trial Overview of Intercell AG 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Sequella, Inc. 43
Clinical Trial Overview of Sequella, Inc. 43
Sanofi 44
Clinical Trial Overview of Sanofi 44
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Silence Therapeutics plc 46
Clinical Trial Overview of Silence Therapeutics plc 46
Archivel Farma S.L. 47
Clinical Trial Overview of Archivel Farma S.L. 47
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Clinical Trial Overview of Otsuka Pharmaceutical Development & Commercialization, Inc. 48
AbbVie Inc. 49
Clinical Trial Overview of AbbVie Inc. 49
Interactive Research and Development 50
Clinical Trial Overview of Interactive Research and Development 50
World Health Advanced Technologies, Ltd. 51
Clinical Trial Overview of World Health Advanced Technologies, Ltd. 51
Clinical Trial Overview of Top Institutes / Government 52
The National Institute of Allergy and Infectious Diseases 52
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52
University of Oxford 56
Clinical Trial Overview of University of Oxford 56
U.S. Centers for Disease Control and Prevention 58
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 58
University of Cape Town 60
Clinical Trial Overview of University of Cape Town 60
National Taiwan University Hospital 62
Clinical Trial Overview of National Taiwan University Hospital 62
National Heart, Lung, and Blood Institute 64
Clinical Trial Overview of National Heart, Lung, and Blood Institute 64
Statens Serum Institut 65
Clinical Trial Overview of Statens Serum Institut 65
Johns Hopkins University 66
Clinical Trial Overview of Johns Hopkins University 66
All India Institute of Medical Sciences 67
Clinical Trial Overview of All India Institute of Medical Sciences 67
Seoul National University Hospital 68
Clinical Trial Overview of Seoul National University Hospital 68
French National Agency for Research on AIDS and Viral Hepatitis 69
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 69
London School of Hygiene & Tropical Medicine 70
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 70
Department of Health, South Africa 71
Clinical Trial Overview of Department of Health, South Africa 71
Global Alliance for TB Drug Development 72
Clinical Trial Overview of Global Alliance for TB Drug Development 72
Tuberculosis Research Centre 73
Clinical Trial Overview of Tuberculosis Research Centre 73
Assistance Publique - Hopitaux de Paris 74
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 74
Asan Medical Center 75
Clinical Trial Overview of Asan Medical Center 75
Aeras Global Tb Vaccine Foundation 76
Clinical Trial Overview of Aeras Global Tb Vaccine Foundation 76
University Medical Center Groningen 77
Clinical Trial Overview of University Medical Center Groningen 77
AIDS Clinical Trials Group 78
Clinical Trial Overview of AIDS Clinical Trials Group 78
Five Key Clinical Profiles 79
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114

List of Tables

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Tuberculosis Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Tuberculosis Therapeutics Clinical Trials, G7 Countries, 2013* 17
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Tuberculosis Therapeutics Clinical Trials, E7 Countries, 2013* 19
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Tuberculosis Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Tuberculosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Tuberculosis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 33
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 34
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2013* 35
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Infectious Diseases, 2013* 36
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec BVBA, 2013* 37
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alaeras, Inc, 2013* 38
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2013* 39
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vakzine Projekt Management GmbH, 2013* 40
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 41
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 42
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2013* 43
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 44
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 45
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics plc, 2013* 46
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archivel Farma S.L., 2013* 47
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Development & Commercialization, Inc., 2013* 48
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 49
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Interactive Research and Development, 2013* 50
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by World Health Advanced Technologies, Ltd., 2013* 51
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 52
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 56
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 58
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2013* 60
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 62
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 64
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2013* 65
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 66
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2013* 67
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 68
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2013* 69
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 70
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2013* 71
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Global Alliance for TB Drug Development, 2013* 72
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuberculosis Research Centre, 2013* 73
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 74
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 75
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeras Global Tb Vaccine Foundation, 2013* 76
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2013* 77
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2013* 78

List of Figures

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Tuberculosis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Tuberculosis Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Tuberculosis Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 112

Read the full report:

Tuberculosis Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/drug_discovery/tuberculosis_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Read the full story at http://www.prweb.com/releases/2013/11/prweb11343483.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. First comprehensive regulatory map is a blueprint for how to defeat tuberculosis
2. Proteome atlas for the tuberculosis pathogen
3. Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
4. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
5. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
6. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
7. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
8. The Role of Central Laboratories in Alzheimer’s Disease Research, a New Global Cliniacal Trials Webinar Hosted by Xtalks
9. Arthroscopy Devices Market is Expected to Reach USD 5.1 Billion Globally in 2019: Transparency Market Research
10. Focus on Green Growth and Environmental Sustainability Drives the Global Market for Marine Biotechnology, According to New Report by Global Industry Analysts, Inc.
11. Global Fertilizer Nutrients Market 2012-2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... 2016 , ... Next week on May 5 at 2:55 ... for tissue stem cell counting and expansion to gene-editing scientists and other attendees ... Genome Engineering in Burlington, Massachusetts. , The attention of most gene-editing scientists appears ...
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... Cambridge ... by semantic web technology, today announced that it has been named to The Silicon ... sciences, financial services and other markets, Cambridge Semantics serves the needs of end users ...
(Date:4/27/2016)... NY (PRWEB) , ... April 27, 2016 , ... ... it. Touch screen mobile devices with fingerprint recognition for secure access, voice ... are only a few ways consumers are interacting with biometrics technology today. ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of Directors of ... John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, ... leaders responsible for the commercialization of multiple orphan drug indications. Mr. Tilton ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/23/2016)... 23, 2016 ... Gesichts- und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler ... mit SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie ... die Möglichkeit angeboten, im Rahmen mobiler Apps ...
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
Breaking Biology News(10 mins):